Mike Boggild

Treatment of Neuromyelitis Optica With Rituximab

Anu Jacob, Brian G. Weinshenker, Ivo Violich et al. · Archives of Neurology · 2008 · 459 citations

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

Joanna Kitley, Maria Isabel Leite, Ichiro Nakashima et al. · Brain · 2012 · 432 citations · Full text

Prognostic Factors, Ocular Disease, Pathology +16

Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients

Liene Elsone, Jay Panicker, Kerry Mutch et al. · Multiple Sclerosis Journal · 2013 · 142 citations

Ocular Disease, Intravenous Immunoglobulin, Immunodeficiencies +20

Incidence and prevalence of NMOSD in Australia and New Zealand

Wajih Bukhari, Kerri Prain, Patrick Waters et al. · Journal of Neurology Neurosurgery & Psychiatry · 2017 · 120 citations · Full text

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future

Mark Pickin, Cindy Cooper, Tim Chater et al. · BMC Neurology · 2009 · 96 citations · Full text